Lenalidomide Maintenance for High Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (alloHCT) with reduced intensity conditioning is an appealing option for patients with high risk multiple myeloma (MM). However, progression after alloHCT remains a challenge. Maintenance therapy after alloHCT may offer additional disease control and all...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Alsina, Melissa, Becker, Pamela S., Zhong, Xiaobo, Adams, Alexia, Hari, Parameswaran, Rowley, Scott, Stadtmauer, Edward A., Vesole, David H., Logan, Brent, Weisdorf, Daniel, Qazilbash, Muzaffar, Popplewell, Leslie L., McClune, Brian, Bensinger, William, Riches, Marcie, Giralt, Sergio A., Pasquini, Marcelo C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036168/
https://ncbi.nlm.nih.gov/pubmed/24769014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.04.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados